Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 10, 2017 (10 years ago)

Fluconazole Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-003-06

Affected NDC 36000-0003-06

Compare with the code on your package — it is the most precise check available.

Drug: Fluconazole

Recalling firm
Claris Lifesciences Inc
NDC code
36000-003-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0614-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluconazole recalls

See all
Class III · Low risk

Fluconazole Injection

Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.

Terminated Wrong potency / content Renaissance Lakewood, LLC D-1033-2018
Class III · Low risk

Fluconazole Injection

Failed Stability Specifications: lot out of specification for elevated water vapor.

Terminated Stability / shelf life Renaissance Lakewood, LLC NDC 36000-002-10 D-1032-2018
Class III · Low risk

Fluconazole Injection

Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Terminated Wrong potency / content Renaissance Lakewood, LLC NDC 36000-003-06 D-1031-2018
Class II · Moderate risk

Fluconazole Injection

Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.

Terminated Labeling / mix-up Renaissance Lakewood, LLC NDC 36000-002-10 D-0696-2018

Other recalls by Claris Lifesciences Inc

All 2017 recalls
Class II · Moderate risk

Metronidazole Injection

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Terminated Sterility / contamination Claris Lifesciences Inc NDC 36000-001-24 D-0616-2017
Class II · Moderate risk

Levofloxacin Injection in 5% Dextrose

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Terminated Sterility / contamination Claris Lifesciences Inc NDC 36000-048-24 D-0615-2017
Class II · Moderate risk

Ciprofloxacin in Dextrose

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Terminated Sterility / contamination Claris Lifesciences Inc NDC 36000-009-24 D-0613-2017